Lek Pharmaceuticals d.d. (primary and secondary packaging, batch release; batch control (only microbiological))
UkraineAll drugs from this manufacturer
-
The drug is used for the prevention and treatment of liver or kidney transplant rejection in adult patients. It may also be used to treat rejection that is resistant to standard immunosuppressive therapy.
Dosage form: capsules, extended-release
Active substance Dosage tacrolimus 1 mg ATC: L04AD02
-
The drug is used for the prevention and treatment of liver or kidney transplant rejection in adult patients, as well as for the treatment of rejection that is resistant to standard immunosuppressive therapy.
Dosage form: capsules, extended-release
Active substance Dosage tacrolimus 3 mg ATC: L04AD02
-
The drug is used for the prevention and treatment of liver or kidney transplant rejection in adult patients, as well as for the treatment of rejection that is resistant to standard immunosuppressive therapy.
Dosage form: capsules, extended-release
Active substance Dosage tacrolimus 5 mg ATC: L04AD02
-
The drug is used for the prevention and treatment of liver or kidney transplant rejection in adult patients. It may also be used to treat rejection that is resistant to standard immunosuppressive therapy.
Dosage form: capsules, extended-release
Active substance Dosage tacrolimus 0.5 mg ATC: L04AD02